Aspire BioPharma

Yahoo Finance • 4 months ago

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Work Medical Technology Group 179,417,612 0.1347 0.106 0.1118 +0.0038 3... Full story

Yahoo Finance • 4 months ago

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, received notice (the "Notice") on Decembe... Full story

Yahoo Finance • 5 months ago

Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin

ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced its successful participation... Full story

Yahoo Finance • 8 months ago

Unusual volume stocks in Thursday's session

Unusual volume stocks are being observed in Thursday's session. [unusualvolume] TOP UNUSUAL VOLUME STOCKS TICKER CHANGE COMMENT THAR [https://www.chartmill.com/stock/quote/THAR/profile] 32.17% THARIMMUNE INC (NASDAQ:THAR... Full story

Yahoo Finance • 8 months ago

Which stocks are experiencing notable movement on Tuesday?

Stay up-to-date with the latest market trends one hour before the close of the markets on Tuesday. Explore the top gainers and losers during today's session in our detailed report. [topmovers] GAINERS TICKER CHANGE COMMENT LA... Full story

Yahoo Finance • 8 months ago

These stocks are moving in today's session

Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT LASE [... Full story

Yahoo Finance • 8 months ago

What's going on in today's session

Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT SNGX... Full story

Yahoo Finance • 8 months ago

Most active stocks in Monday's session

Get a pulse on the US markets on Monday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity. [mostactive] TOP MOST ACTIVE STOCKS TICKE... Full story

Yahoo Finance • 8 months ago

Monday's session: top gainers and losers

Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session. [topmovers] GAINERS TICKER CHANGE COMMENT SNGX [https://www.chartmill... Full story

Yahoo Finance • 8 months ago

Let's uncover which stocks are experiencing notable gaps during today's session.

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps. [gap] TOP GAP UP STOCKS TICKER CHANGE COM... Full story

Yahoo Finance • 8 months ago

Aspire Biopharma names new executive chair

* Aspire Biopharma (NASDAQ:ASBP [https://seekingalpha.com/symbol/ASBP]) said that [https://seekingalpha.com/pr/20183948-aspire-biopharma-holdings-inc-announces-ceo-transition] Board of Directors has appointed Kraig Higginson as interim C... Full story

Yahoo Finance • 9 months ago

Aspire Biopharma to launch sublingual pre-workout supplement at fitness expos

ESTERO, FL - Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP), a micro-cap company currently valued at $20 million, plans to introduce its new sublingual pre-workout supplement, BUZZ BOMB, at two major fitness conventions in early August, acc... Full story

Yahoo Finance • 10 months ago

Aspire Biopharma Holdings, Inc., Announces Last Patient Dosed in Phase 1 Clinical Trial of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

Enrollment Completed on Schedule; Topline Results Expected Mid Q3 2025 ESTERO, FL AND NEW YORK, NY / ACCESS Newswire / June 24, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted... Full story